$4.75
+0.24 (+5.32%)
Open$4.62
Previous Close$4.51
Day High$4.82
Day Low$4.60
52W High$12.70
52W Low$6.20
Volume—
Avg Volume17.8K
Market Cap1.92M
P/E Ratio—
EPS$-4.96
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+104.6% upside
Current
$4.75
$4.75
Target
$9.72
$9.72
$6.32
$9.72 avg
$10.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 493.3K | 481.3K | 473.6K |
| Net Income | 115.4K | 80.6K | 101.2K |
| Profit Margin | 23.4% | 16.8% | 21.4% |
| EBITDA | 189.6K | 155.0K | 161.9K |
| Free Cash Flow | 102.8K | 100.3K | 125.4K |
| Rev Growth | +17.7% | -1.9% | +10.9% |
| Debt/Equity | 0.11 | 0.15 | 0.11 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |